Inmunodeficiencias primarias: inmunopatogenia, infecciones asociadas y estrategias terapéuticas

dc.contributor.authorSiham Salmen
dc.contributor.authorRima Bahsas Zaky
dc.contributor.authorNubia Silva
dc.contributor.authorLuisa Barboza
dc.contributor.authorGuillermo Terán Ángel
dc.contributor.authorLisbeth Berrueta
dc.contributor.authorRaian Contreras Cardone
dc.contributor.authorAstrid Cantor Garcia
dc.contributor.authorFabiola Silva
dc.contributor.authorYanett Guzman Escalona
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T17:02:18Z
dc.date.available2026-03-22T17:02:18Z
dc.date.issued2013
dc.description.abstractPrimary immunodeficiencies disorders (PID) are a group of genetic defects that affect both innate and adaptive immune response. PID are associated with: 1) absence of cellular components, 2) impaired connection among components of the immune response, as well as in the recognition of foreign, self or modified antigens, and 3) inappropriate modulation of effectors mechanisms either by inability to reach affected tissues, to promote proinflammatory and regulatory polarization, or perform the clearance of invading agents. PID not only increases the susceptibility to infections by different microorganisms, but also alters the homeostatic mechanisms and immune surveillance, that prevent autoinflammatory and neoplastic diseases. This review describes some of these defects, its consequences and the initial approach to the study and management of recurrent infections.
dc.identifier.urihttps://dialnet.unirioja.es/servlet/oaiart?codigo=4796924
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/61796
dc.language.isoen
dc.publisherUniversidad Internacional de La Rioja
dc.relation.ispartofDialnet (Universidad de la Rioja)
dc.sourceUniversidad de Los Andes
dc.subjectMedicine
dc.titleInmunodeficiencias primarias: inmunopatogenia, infecciones asociadas y estrategias terapéuticas
dc.typearticle

Files